CME Group climbs after JPM upgrades stock to 'overweight'

By Reuters News

** Shares of derivatives marketplace CME Group CME.O rise 0.8% to $298 premarket

** J.P.Morgan upgrades CME to "overweight" from "underweight"; sets $367 PT, implying 24% upside to last close

** CME is well-positioned to outperform as interest-rate environment is constructive for driving higher trading velocity, brokerage says

** "CME activity benefits in particular when longer term rates (where market participants may have less certainty about the outlook) are rising. A continuation of the Fed Funds hiking cycle also bodes well for more elevated velocity and upward volume revisions" - JPM

** Nine of 18 brokerages rate the stock "buy" or higher, 6 "hold" and 3 "sell"; median PT $328 - LSEG data

** As of last close, CME shares up 8.3% YTD

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.